Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment
Medtronic has announced approval from the USA Food and Drug Administration (FDA) for the Symplicity Spyral renal denervation (RDN) system for the treatment of...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented at VEITHsymposium 2023
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...
New study reviews the survival rate of patients withdrawing from dialysis
Data that was presented at the American Society of Nephrology (ASN) Kidney Week meeting (2–5 November 2023, Philadelphia, USA) shows that patients who have...
AcelRx to host a panel discussion on current anticoagulant use in dialysis
AcelRx Pharmaceuticals have announced that they will be hosting a key opinion leader (KOL) panel discussion virtually to explore its lead candidate Niyad for...
